Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber Loren O King

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cureus|September 19, 2022
Factors Associated With In-Hospital Mortality in Mycosis Fungoides Patients: A Multivariable AnalysisAmber Loren O King, Victor Lee, Fatima N Mirza, et al.
Frontiers in Oncology|May 24, 2023
The role of imaging and sentinel lymph node biopsy in patients with T3b-T4b melanoma with clinically negative diseaseMarianna V Papageorge, Renee M Maina, Amber Loren O King, et al.
Blood Advances|May 22, 2020
JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCLSara Yumeen, Fatima N Mirza, Julia M Lewis, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cureus|September 19, 2022
Factors Associated With In-Hospital Mortality in Mycosis Fungoides Patients: A Multivariable AnalysisAmber Loren O King, Victor Lee, Fatima N Mirza, et al.
Frontiers in Oncology|May 24, 2023
The role of imaging and sentinel lymph node biopsy in patients with T3b-T4b melanoma with clinically negative diseaseMarianna V Papageorge, Renee M Maina, Amber Loren O King, et al.
Blood Advances|May 22, 2020
JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCLSara Yumeen, Fatima N Mirza, Julia M Lewis, et al.
Pageof 1